76 related articles for article (PubMed ID: 21138349)
21. Pharmacokinetic interaction between darunavir and saquinavir in HIV-negative volunteers.
Sekar VJ; Lefebvre E; Mariën K; De Pauw M; Vangeneugden T; Hoetelmans RM
Ther Drug Monit; 2007 Dec; 29(6):795-801. PubMed ID: 18043478
[TBL] [Abstract][Full Text] [Related]
22. Darunavir: pharmacokinetics and drug interactions.
Back D; Sekar V; Hoetelmans RM
Antivir Ther; 2008; 13(1):1-13. PubMed ID: 18389894
[TBL] [Abstract][Full Text] [Related]
23. Transport of Schisandra chinensis extract and its biologically-active constituents across Caco-2 cell monolayers - an in-vitro model of intestinal transport.
Madgula VL; Avula B; Choi YW; Pullela SV; Khan IA; Walker LA; Khan SI
J Pharm Pharmacol; 2008 Mar; 60(3):363-70. PubMed ID: 18284817
[TBL] [Abstract][Full Text] [Related]
24. Differential roles of P-glycoprotein, multidrug resistance-associated protein 2, and CYP3A on saquinavir oral absorption in Sprague-Dawley rats.
Usansky HH; Hu P; Sinko PJ
Drug Metab Dispos; 2008 May; 36(5):863-9. PubMed ID: 18256206
[TBL] [Abstract][Full Text] [Related]
25. P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice.
Park S; Sinko PJ
J Pharmacol Exp Ther; 2005 Mar; 312(3):1249-56. PubMed ID: 15528451
[TBL] [Abstract][Full Text] [Related]
26. The inhibition effect of garlic-derived compounds on human immunodeficiency virus type 1 and saquinavir.
Gökalp F
J Biochem Mol Toxicol; 2018 Nov; 32(11):e22215. PubMed ID: 30194790
[TBL] [Abstract][Full Text] [Related]
27. Nicotine and cotinine increases the brain penetration of saquinavir in rat.
Manda VK; Mittapalli RK; Bohn KA; Adkins CE; Lockman PR
J Neurochem; 2010 Dec; 115(6):1495-507. PubMed ID: 20950334
[TBL] [Abstract][Full Text] [Related]
28. Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein.
Kim AE; Dintaman JM; Waddell DS; Silverman JA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1439-45. PubMed ID: 9732409
[TBL] [Abstract][Full Text] [Related]
29. The effect of garlic supplements on the pharmacokinetics of saquinavir.
Piscitelli SC; Burstein AH; Welden N; Gallicano KD; Falloon J
Clin Infect Dis; 2002 Jan; 34(2):234-8. PubMed ID: 11740713
[TBL] [Abstract][Full Text] [Related]
30. In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal p-glycoprotein by ritonavir causing increased darunavir absorption.
Holmstock N; Mols R; Annaert P; Augustijns P
Drug Metab Dispos; 2010 Sep; 38(9):1407-10. PubMed ID: 20551242
[TBL] [Abstract][Full Text] [Related]
31. Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice.
Holmstock N; Annaert P; Augustijns P
Drug Metab Dispos; 2012 Aug; 40(8):1473-7. PubMed ID: 22550269
[TBL] [Abstract][Full Text] [Related]
32. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
33. Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir.
Janneh O; Hartkoorn RC; Jones E; Owen A; Ward SA; Davey R; Back DJ; Khoo SH
Br J Pharmacol; 2008 Nov; 155(6):875-83. PubMed ID: 19002102
[TBL] [Abstract][Full Text] [Related]
34. Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents.
Hashiguchi Y; Hamada A; Shinohara T; Tsuchiya K; Jono H; Saito H
Biochem Biophys Res Commun; 2013 Sep; 439(2):221-7. PubMed ID: 23981805
[TBL] [Abstract][Full Text] [Related]
35. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2).
Lalloo AK; Luo FR; Guo A; Paranjpe PV; Lee SH; Vyas V; Rubin E; Sinko PJ
BMC Med; 2004 May; 2():16. PubMed ID: 15125776
[TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.
Janneh O; Anwar T; Jungbauer C; Kopp S; Khoo SH; Back DJ; Chiba P
Antivir Ther; 2009; 14(7):965-74. PubMed ID: 19918100
[TBL] [Abstract][Full Text] [Related]
37. Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: a study in ex vivo lung models using chemical inhibition and genetic knockout.
Al-Jayyoussi G; Price DF; Francombe D; Taylor G; Smith MW; Morris C; Edwards CD; Eddershaw P; Gumbleton M
J Pharm Sci; 2013 Sep; 102(9):3382-94. PubMed ID: 23670704
[TBL] [Abstract][Full Text] [Related]
38. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
Panchagnula R; Bansal T; Varma MV; Kaul CL
Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
[TBL] [Abstract][Full Text] [Related]
39. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Kakuda TN; Falcon RW
Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
[TBL] [Abstract][Full Text] [Related]
40. Functional role of P-glycoprotein in the human blood-placental barrier.
Mölsä M; Heikkinen T; Hakkola J; Hakala K; Wallerman O; Wadelius M; Wadelius C; Laine K
Clin Pharmacol Ther; 2005 Aug; 78(2):123-31. PubMed ID: 16084847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]